Primary prevention, smoking, and smoking cessation : Implications for future trends in lung cancer preventionBURNS, David M.Cancer. 2000, Vol 89, Num 11, pp 2506-2509, issn 0008-543X, SUPConference Paper

Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative diseaseBURNS, David M; CRAWFORD, Dorothy H.Blood reviews. 2004, Vol 18, Num 3, pp 193-209, issn 0268-960X, 17 p.Article

Hardening and the hard-core smoker: concepts, evidence, and implicationsWARNER, Kenneth E; BURNS, David M.Nicotine & tobacco research. 2003, Vol 5, Num 1, pp 37-48, issn 1462-2203, 12 p.Article

Modern Pavement Marking Systems : Relationship Between Optics and Nighttime VisibilityBURNS, David M; HEDBLOM, Thomas P; MILLER, Terry W et al.Transportation research record. 2008, Num 2056, pp 43-51, issn 0361-1981, 9 p.Article

Pavement marking photometric performance and visibility under dry, wet, and rainy conditions : Pilot field studyBURNS, David M; HODSON, Neil; HAUNSCHILD, Dale et al.Transportation research record. 2006, Num 1973, pp 113-119, issn 0361-1981, 7 p.Article

State-specific trends in smoke-free workplace policy coverage : The current population Survey Tobacco Use supplement, 1993 to 1999SHOPLAND, Donald R; GERLACH, Karen K; BURNS, David M et al.Journal of occupational and environmental medicine. 2001, Vol 43, Num 8, pp 680-686, issn 1076-2752Article

Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWENQING YAO; JINCONG ZHUO; MARANDO, Cindy A et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 1, pp 159-163, issn 0960-894X, 5 p.Article

Smoking Cessation Interventions for Hospitalized Smokers : A Systematic Review. CommentaryBURNS, David M; RIGOTTI, Nancy A; MUNAFO, Marcus R et al.Archives of internal medicine (1960). 2008, Vol 168, Num 18, issn 0003-9926, 1946-1947, 1950-1960 [13 p.]Article

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of Epstein-Barr virus-associated diseasesWILKIE, Gwen M; TAYLOR, Clare; JONES, Marie M et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 4, pp 309-316, issn 1524-9557, 8 p.Article

Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionBURNS, David M; LI, Yun-Long; COVINGTON, Maryanne B et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 13, pp 3525-3530, issn 0960-894X, 6 p.Article

Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P'₁ permutationsBURNS, David M; CHUNHONG HE; FRIDMAN, Jordan S et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 2, pp 560-564, issn 0960-894X, 5 p.Article

Association between home smoking restrictions and changes in smoking behaviour among employed womenSHOPLAND, Donald R; ANDERSON, Christy M; BURNS, David M et al.Journal of epidemiology and community health (1979). 2006, Vol 60, issn 0143-005X, ii44-ii50, SUP2Article

Lung Cancer mortality is related to age in addition to duration and intensity of cigarette smoking: An analysis of CPS-I dataKNOKE, James D; SHANKS, Thomas G; VAUGHN, Jerry W et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 6, pp 949-957, issn 1055-9965, 9 p.Article